1. Home
  2. CETX vs EOCN Comparison

CETX vs EOCN Comparison

Compare CETX & EOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

N/A

Current Price

$0.45

Market Cap

3.5M

Sector

Technology

ML Signal

N/A

EOCN

Eocene Ltd. Ordinary Shares

N/A

Current Price

$1.82

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CETX
EOCN
Founded
1998
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
2.9M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
CETX
EOCN
Price
$0.45
$1.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.1M
6.9K
Earning Date
12-28-2026
11-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $120,628,200.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 28.73
N/A
52 Week Low
$0.44
$2.05
52 Week High
$97.00
$3.80

Technical Indicators

Market Signals
Indicator
CETX
EOCN
Relative Strength Index (RSI) 13.42 23.22
Support Level N/A N/A
Resistance Level $3.15 $2.98
Average True Range (ATR) 0.12 0.31
MACD -0.02 -0.06
Stochastic Oscillator 4.20 3.57

Price Performance

Historical Comparison
CETX
EOCN

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded into a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. The company's operating segment includes the Security segment and the Industrial Services segment. The security segment provides end-to-end security to all industrial, corporate, and governmental security via its owned subsidiary, Vicon. Whereas the AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in-plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment, and from the USA. It also operates UK, USA, and Other.

About EOCN Eocene Ltd. Ordinary Shares

Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices for postoperative colorectal care, including CG-100, an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas. The company's therapeutic portfolio includes Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule being evaluated in liver disease and oncology indications, including gastrointestinal cancers.

Share on Social Networks: